ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA. J Popl Ther Clin Pharmacol. 2024;31(9):731-740. doi:10.53555/nhwgvd87